The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines

Immunity

Volumn 10, Issue 6, 1999, Pages 745-751

  Kim, James I ^a   Ho, I Cheng ^a,b   Grusby, Michael J ^a,b   Glimcher, Laurie H ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 4; LEUCINE ZIPPER PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GENE EXPRESSION; GENE INACTIVATION; GENETIC TRANSCRIPTION; HELPER CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

EID: 0033152267     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80073-4     Document Type: Article

References (50)

1. Aversa, G., Punnonen, J., Cocks, B.C., de Waal Malefyt, R., Vega, F., Zurawski, S.M., Zurawski, G., and deVries, J.E. (1993). An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: Support for a common component shared by IL-4 and IL-13 receptors. J. Exp. Med. 178, 2213-2218.
2. Barner, M., Mohrs, M., Brombacher, F., and Kopf, M. (1998). Differences between IL-4Ra-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr. Biol. 8, 669-672.
3. Bendelac, A., Hunziker, R.D., and Lantz, O. (1996). Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J. Exp. Med. 184, 1285-1293.
4. Bost, K.L., Holton, R.H., Cain, T.K., and Clements, J.D. (1996). In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice. Immunology 87, 633-641.
5. Brown, K.D., Zurawski, S.M., Mosmann, T.R., and Zurawski, G. (1989). A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J. Immunol. 142, 679-687.
6. Brown, D.R., Fowell, D.J., Corry, D.B., Wynn, T.A., Moskowitz, N.H., Cheever, A.W., Locksley, R.M., and Reiner, S.L. (1996). B2-microglobulin-dependent NK1.1+ T cells are not essential for T helper cell 2 immune responses. J. Exp. Med. 184, 1295-1304.
7. Chiaramonte, M.G., Schopf, L.R., Neben, T.Y., Cheever, A.W., Donaldson, D.D., and Wynn, T.A. (1999). IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J. Immunol. 162, 920-930.
8. Cohn, L., Tepper, J.S., and Bottomly, K. (1998). Cutting edge: IL-4-Independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J. Immunol. 161, 3813-3816.
9. Csonga, R., Prieschl, E.E., Jaksche, D., Novotny, V., and Baumruker, T. (1998). Common and distinct signaling pathways mediate the induction of TNF-α and IL-5 in IgE plus antigen-stimulated mast cells. J. Immunol. 160, 273-283.
10. de Waal Malefyt, R., Figdor, C.G., Huijbens, R., Mohan-Peterson, S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G., and deVries, J.E. (1993). Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 151, 6370-6381.
11. Defrance, T., Carayon, P., Billian, G., Guillemot, J.C., Minty, A., Caput, D., and Ferrara, P. (1994). Interleukin 13 is a B cell stimulating factor. J. Exp. Med. 179, 135-143.
12. Doherty, T.M., Kastelein, R., Menon, S., Andrade, S., and Coffman, R.L. (1993). Modulation of murine macrophage function by IL-13. J. Immunol. 151, 7151-7160.
13. Emson, C.L., Bell, S.E., Jones, A., Wisden, W., McKenzie, A.N.J., and de Vries, J.E. (1998). Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T cell development in transgenic mice expressing IL-13. J. Exp. Med. 188, 399-404.
14. Finkelman, F.D., Katona, I.M., Urban, J.F., Jr., Holmes, J., Ohara, J., Tung, A.S., Sample, J.V., and Paul, W.E. (1988). IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141, 2335-2341.
15. Glimcher, L.H., and Singh, H. (1999). Transcription factors in lymphocyte development - T and B cells get together. Cell 96, 13-23.
16. Grunig, G., Warnock, M., Wakil, A.E., Venkayya, R., Brombacher, F., Rennick, D.M., Sheppard, D., Mohrs, M., Donaldson, D.D., Locksley, R.M., et al. (1998). Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282, 2261-2263.
17. Heinzel, F.P., Sadick, M.D., Holaday, B.J., Coffman, R.L., and LocksLey, R.M. (1989). Reciprocal expression of interferon γ or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. Med. 169, 59-72.
18. Ho, I-C., Hodge, M.R., Rooney, J.W., and Glimcher, L.H. (1996). The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell 85, 973-983.
19. Ho, I-C., Lo, D., and Glimcher, L.H. (1998). C-maf promotes Th2 and attenuates Th1 differentiation by both IL-4 dependent and independent mechanisms. J. Exp. Med. 188, 1859-1866.
20. Hodge, M.R., Chun, H.J., Rengarajan, J., Alt, A., Lieberson, R., and Glimcher, L.H. (1996a). NFAT-driven interleukin-4 transcription potentiated by NIP45. Science 274, 1903-1905.
21. Hodge, M.R., Ranger, A.M., Charles de la Brousse, F., Hoey, T., Grusby, M.J., and Glimcher, L.H. (1996b). Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity 4, 1-20.
22. Hogan, S.P., Matthaei, K.I., Young, J.M., Koshinen, A., Young, I.G., and Foster, P.S. (1998). A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol. 161, 1501-1509.
23. Hoshino, T., Winkler-Pickett, R.T., Mason, A.T., Ortaldo, J.R., and Young, H.A. (1999). IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-γ. J. Immunol. 162, 51-59.
24. Kaplan, M.H., Schindler, U., Smiley, S.T., and Grusby, M.J. (1996). Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4, 313-319.
25. Kaplan, M.H., Whitfield, J.R., Boros, D.L., and Grusby, M.J. (1998). Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J. Immunol. 160, 1850-1856.
26. Kim, J.I., Li, T., Ho, I., Grusby, M., and Glimcher, L.H. (1999). Requirement for the c-maf transcription factor in crystallin gene regulation and lens development. Proc. Natl. Acad. Sci. USA 96, 3781-3785.
27. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M.C., Bluethmann, H., and Kohler, G. (1993). Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362, 245-248.
28. Kuchroo, V.K., Das, M.P., Brown, J.A., Ranger, A.M., Zamvil, S.S., Sobel, R.A., Nabavi, N., and Glimcher, L.H. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80, 707-718.
29. Kuhn, R., Rajewsky, K., and Muller, W. (1991). Generation and analysis of interleukin-4 deficient mice. Science 254, 707-710.
30. Lee, H.J., Koyano-Nakagawa, N., Naito, Y., Nishida, J., Arai, N., Arai, K., and Yokota, T. (1993). cAMP activates the IL-5 promoter synergistically with phorbol ester through the signaling pathway involving protein kinase A in mouse thymoma line EL-4. J. Immunol. 151, 6135-6142.
31. McKenzie, A.N.J., Culpepper, J.A., Malefyt, R.D.W., Briere, F., Punnonen, J., Aversa, G., Sato, A., Dang, W., Cocks, B.G., Menon, S., et al. (1993). Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc. Natl. Acad. Sci. USA 90, 3735-3739.
32. McKenzie, G.J., Emson, C.L., Bell, S.E., Anderson, S., Fallon, P., Zurawski, G., Murray, R., Grencis, R., and McKenzie, A.N.J. (1998). Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9, 423-432.
33. Minty, A., Chalon, P., Derocq, J.-M., Dumont, X., Guillemot, J.-C., Kaghad, M., Labit, C., Leplatois, P., Liauzun, P., Miloux, B., et al. (1993). Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362, 248-250.
34. Mosmann, T.R., Cherwinski, H., Bond, M.W., Giedlin, M.A., and Coffman, R.L. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
35. + T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 94, 10838-10843.
36. Ouyang, W., Ranganath, S.H., Weindel, K., Bhattacharya, D., Murphy, T.L., Sha, W.C., and Murphy, K.M. (1998). Inhibition of Th1 development mediated by GATA-3 through an IL-4 independent mechanism. Immunity 9, 745-755.
37. Paul, W.E., and Seder, R.A. (1994). Lymphocyte responses and cytokines. Cell 76, 241-251.
38. Punnonen, J., Aversa, G., Cocks, B.G., McKenzie, A.N.J., Menon, S., Zurawski, G., de Waal Malefyt, R., and de Vries, J.E. (1993). Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA 90, 3730-3734.
39. Sadick, M.D., Heinzel, F.P., Holaday, B.J., Pu, R.T., Dawkins, R.S., and Locksley, R.M. (1990). Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-dependent mechanism. J. Exp. Med. 171, 115-127.
40. Shimoda, K., van Deursen, J., Sangster, M.Y., Sarawar, S.R., Carson, R.T., Tripp, R.A., Chu, C., Quelle, F.W., Nosaka, T., Vignali, D.A., et al. (1996). Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380, 630-633.
41. Smiley, S.T., Kaplan, M.H., and Grusby, M.J. (1997). Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science 275, 977-979.
42. Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S., Nakanishi, K., Yoshida, N., Kishimoto, T., and Akira, S. (1996). Essential role of Stat6 in IL-4 signaling. Nature 380, 627-630.
43. +Nk1.1- T cell population. J. Immunol. 157, 4421-4427.
44. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L., and Donaldson, D.D. (1998). Interleukin-13: Central mediator of allergic asthma. Science 282, 2258-2261.
45. Yamagata, T., Mitani, K., Ueno, H., Kanda, Y., Yazaki, Y., and Hirai, H. (1997). Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells. Mol. Cell. Biol. 17, 4272-4281.
46. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 179, 1285-1295.
47. Zhang, Y., Rogers, K.H., and Lewis, D.B. (1996). Beta-2-microglobulin-dependent T cells are dispensable for allergen-induced T helper 2 responses. J. Exp. Med. 184, 1507-1512.
48. Zhang, D.H., Cohn, L., Ray, P., Bottomly, K., and Ray, A. (1997). Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272, 21597-21603.
49. Zheng, W-P., and Flavell, R.A. (1997). The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596.
50. Zurawski, S.M., Vega, F., Huyghe, B., and Zurawski, G. (1993). Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J. 12, 2663-2670.